CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Padagis Israel Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Padagis Israel Pharmaceuticals Ltd
RAKEFET 1
Phone: +972 35773700p:+972 35773700 SHOHAM, 5120050  Israel Ticker: AGISAGIS

This is a Subsidiary, click here for the Parent Company

Business Summary
Padagis Israel Pharmaceuticals Ltd, formerly Perrigo Israel Pharmaceuticals Ltd, is an Israel-based company which develops, manufactures and sells generic drugs primarily for the United States (US) and domestic markets, and imports, sells and distributes brand name drugs and generics, and medical and diagnostic equipment in Israel.The Company develops and manufactures pharmaceutical formulations with complex technologies, such as foams, nasal sprays and hormone products, as well as a wide range of dermatology, vaginal and other products. Padagis Israel Pharmaceuticals Ltd represents and distributes in Israel the products of pharmaceutical and diagnostic companies, including: Aspen, Grifols, GSK, Sandoz, Siemens Healthcare, Ascensia Diabetes Care (Ex. Bayer Diabetes Care), Cupron, Pierre Fabre, Sakura Finetek, Dexcom Inc. Celltrion Healthcare.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200412/31/2004Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President Moshe (Mori)Arkin
Chief Executive Officer, Director Rafael (Rafi)Lebel 1/1/2003
Vice President-Finance DovFeldman
9 additional Officers and Directors records available in full report.

Business Names
Business Name
AGIS
Agis Industries (1983) Ltd.
Padagis Israel Pharmaceuticals Ltd.

General Information
Number of Employees: 1,900 (As of 12/31/2002)
Outstanding Shares: 29,684,000 (As of 12/31/2004)
Shareholders: 19,211
Stock Exchange: TLV
Fax Number: +972 35773500


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023